Pfizer Inc

Roche’s Alecensa halted the spread of lung cancer for longer time than treatment with Pfizer’s Xalkori

by News Hour Correspondent - Jun 5, 2017

News Hour: Roche Holding AG’s Alecensa halted the spread of lung cancer for a median of 15 months longer than treatment with rival Pfizer Inc’s Xalkori with fewer side effects, according to trial results presented on...
U.S. health regulators approved Pfizer Inc’s immuno-oncology drug Bavencio to treat advanced bladder cancer

by News Hour Correspondent - May 10, 2017

News Hour: U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc’s immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with...
Pfizer Inc’s process for manufacturing contaminated drugs at a plant Kansas was “out of control”, warns FDA

by News Hour Correspondent - Mar 1, 2017

News Hour: The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas was “out of control” and put patients at risk, according to a warning...
Pfizer gives up it’s plan to split into two companies

by News Hour Correspondent - Sep 26, 2016

News Hour: U.S. drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it will not do so because the move would not create any shareholder...